Skip to main content

Table 1 Characteristics of subgroups based on the presence of sICH

From: Hypersensitive C-reactive protein-albumin ratio predicts symptomatic intracranial hemorrhage after endovascular therapy in acute ischemic stroke patients

Variable

sICH group (n=37)

Non-sICH group (n=297)

P

Demographic characteristics

 Age, years

73.2 ±10.9

68.5 ±11.2

0.016

 Male, %

23 (62.2)

187 (63.0)

0.904

Vascular risk factors, %

 Hypertension

32 (86.5)

197 (66.3)

0.014

 Diabetes mellitus

9 (24.3)

58 (19.5)

0.515

 Dyslipidemia

7 (18.9)

93 (31.3)

0.132

 Coronary heart disease

12 (32.4)

63 (21.2)

0.529

 Atrial fibrillation

14 (37.8)

85 (28.6)

0.076

 Previous stroke

9 (24.3)

70 (23.6)

0.100

 Current drinking

8 (21.6)

82 (27.6)

0.421

 Current smoking

9 (24.3)

102 (34.3)

0.144

Clinical data

 Previous antiplatelet, %

14 (37.8)

47 (15.8)

0.003

 SBP, mmHg

149.7 ±22.7

139.8 ±23.9

0.017

 DBP, mmHg

84.1 ±17.7

85.2 ±14.6

0.668

 Body mass index, kg/m2

24.2 ±3.8

24.1 ±3.7

0.919

 Initial NIHSS, score

16 (13, 22)

15 (11, 19)

0.043

 Intravenous thrombolysis, %

21 (56.8)

122 (41.1)

0.069

 Time from door to puncture, min

120.0 (90.5, 149.0)

110.0 (75.0, 140.0)

0.075

 Number of thrombectomy device passes

2 (1, 3)

2 (1, 3)

0.048

 Poor collateral status, %

23 (62.2)

135 (45.5)

0.055

 Successful recanalization, %

33 (89.2)

256 (86.2)

0.800

Stroke subtype, %

  

0.169

 LAA

12 (32.4)

139 (46.8)

 

 CE

21 (56.8)

121 (40.7)

 

 Other subtype

4 (10.8)

37 (12.5)

 

Laboratory data

 TC, mmol/L

4.2 ±1.2

4.4 ±1.2

0.537

 TG, mmol/L

1.1 (0.8, 1.7)

1.1 (0.8, 1.6)

0.375

 LDL, mmol/L

2.6 (1.9, 3.2)

2.6 (2.0, 3.2)

0.469

 HDL, mmol/L

1.1±0.3

1.1±0.4

0.865

 FBG, mmol/L

9.0 ±3.5

6.9 ±2.4

0.001

 Homocysteine, μmol/L

12.8 (10.7, 16.0)

12.3 (10.4, 15.8)

0.588

 HAR, 10−3

0.54 (0.24, 1.55)

0.17 (0.09, 0.33)

0.001

  1. Abbreviation: NIHSS, National institute of health stroke scale, SBP Systolic blood pressure, DBP Diastolic blood pressure, LAA Large-artery atherosclerosis, CE Cardioembolism, TC Total cholesterol, TG Triglyceride, LDL Low-density lipoprotein, HDL High-density lipoprotein, FBG Fasting blood glucose, HAR Hypersensitive C-reactive protein-albumin ratio